Targeting a human protein may stop Ebola virus in its tracks
The Pharma Data
MARCH 23, 2022
Back in 2018, researchers tested a broad-spectrum antiviral candidate called remdesivir/VEKLURY, which acts as a nucleotide decoy to get incorporated into the viral RNA genome and stop viral polymerase. A new route for interfering with Ebola virus infection. But targeting Ebola virus polymerase has proven tough.
52 
Let's personalize your content